Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1943 1
1944 1
1945 5
1946 4
1948 1
1949 1
1951 1
1952 1
1954 1
1955 1
1968 1
1973 1
1975 1
1978 1
1979 1
1980 2
1981 2
1982 4
1983 2
1985 1
1987 2
1988 2
1989 6
1990 5
1991 2
1992 3
1993 3
1994 2
1995 2
1996 4
1997 1
1998 4
1999 4
2000 4
2001 7
2002 9
2003 10
2004 10
2005 15
2006 9
2007 8
2008 12
2009 19
2010 22
2011 35
2012 48
2013 42
2014 57
2015 24
2016 39
2017 55
2018 74
2019 94
2020 90
2021 103
2022 102
2023 110
2024 87

Text availability

Article attribute

Article type

Publication date

Search Results

1,099 results

Results by year

Filters applied: . Clear all
Page 1
Gastric cancer epidemiology and risk factors.
Guggenheim DE, Shah MA. Guggenheim DE, et al. Among authors: shah ma. J Surg Oncol. 2013 Mar;107(3):230-6. doi: 10.1002/jso.23262. Epub 2012 Nov 5. J Surg Oncol. 2013. PMID: 23129495 Review.
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors.
Starodub AN, Ocean AJ, Shah MA, Guarino MJ, Picozzi VJ Jr, Vahdat LT, Thomas SS, Govindan SV, Maliakal PP, Wegener WA, Hamburger SA, Sharkey RM, Goldenberg DM. Starodub AN, et al. Among authors: shah ma. Clin Cancer Res. 2015 Sep 1;21(17):3870-8. doi: 10.1158/1078-0432.CCR-14-3321. Epub 2015 May 5. Clin Cancer Res. 2015. PMID: 25944802 Free PMC article. Clinical Trial.
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH. Fuchs CS, et al. Among authors: shah ma. JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013. Epub 2018 May 10. JAMA Oncol. 2018. PMID: 29543932 Free PMC article. Clinical Trial.
Anaplastic thyroid cancer.
Ranganath R, Shah MA, Shah AR. Ranganath R, et al. Among authors: shah ma. Curr Opin Endocrinol Diabetes Obes. 2015 Oct;22(5):387-91. doi: 10.1097/MED.0000000000000189. Curr Opin Endocrinol Diabetes Obes. 2015. PMID: 26313900 Review.
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study.
Thuss-Patience PC, Shah MA, Ohtsu A, Van Cutsem E, Ajani JA, Castro H, Mansoor W, Chung HC, Bodoky G, Shitara K, Phillips GDL, van der Horst T, Harle-Yge ML, Althaus BL, Kang YK. Thuss-Patience PC, et al. Among authors: shah ma. Lancet Oncol. 2017 May;18(5):640-653. doi: 10.1016/S1470-2045(17)30111-0. Epub 2017 Mar 23. Lancet Oncol. 2017. PMID: 28343975 Clinical Trial.
Glass-blowers' cataract.
SHAH MA. SHAH MA. Ind Med Gaz. 1945;80(8):400-2. Ind Med Gaz. 1945. PMID: 21003717 Free PMC article. No abstract available.
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium.
Sperotto F, Gutiérrez-Sacristán A, Makwana S, Li X, Rofeberg VN, Cai T, Bourgeois FT, Omenn GS, Hanauer DA, Sáez C, Bonzel CL, Bucholz E, Dionne A, Elias MD, García-Barrio N, González TG, Issitt RW, Kernan KF, Laird-Gion J, Maidlow SE, Mandl KD, Ahooyi TM, Moraleda C, Morris M, Moshal KL, Pedrera-Jiménez M, Shah MA, South AM, Spiridou A, Taylor DM, Verdy G, Visweswaran S, Wang X, Xia Z, Zachariasse JM; Consortium for Clinical Characterization of COVID-19 by EHR (4CE); Newburger JW, Avillach P. Sperotto F, et al. Among authors: shah ma. EClinicalMedicine. 2023 Sep 14;64:102212. doi: 10.1016/j.eclinm.2023.102212. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37745025 Free PMC article.
Osteoanabolics.
Gupta V, Shah MA, Shah SK, Shah JM. Gupta V, et al. Among authors: shah ma. Indian J Endocrinol Metab. 2012 May;16(3):349-57. doi: 10.4103/2230-8210.95662. Indian J Endocrinol Metab. 2012. PMID: 22629498 Free PMC article.
Nanomaterial Induced Immune Responses and Cytotoxicity.
Ali A, Suhail M, Mathew S, Shah MA, Harakeh SM, Ahmad S, Kazmi Z, Alhamdan MA, Chaudhary A, Damanhouri GA, Qadri I. Ali A, et al. Among authors: shah ma. J Nanosci Nanotechnol. 2016 Jan;16(1):40-57. doi: 10.1166/jnn.2016.10885. J Nanosci Nanotechnol. 2016. PMID: 27398432 Review.
1,099 results